Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
MECOM mutation + KDM6B mutation
i
Other names:
KDM6B, Lysine Demethylase 6B, Jumonji Domain Containing 3 Histone Lysine Demethylase, Jumonji Domain-Containing Protein 3, Lysine (K)-Specific Demethylase 6B, JmjC Domain-Containing Protein 3, Lysine-Specific Demethylase 6B, JMJD3, Jumonji Domain Containing, KIAA0346, NEDCFSA, MECOM, MDS1 And EVI1 Complex Locus, PRDM3, Ecotropic Virus Integration Site 1 Protein Homolog, Myelodysplasia Syndrome-Associated Protein 1, Histone-Lysine N-Methyltransferase MECOM, PR Domain 3, MDS1-EVI1, KMT8E, EVI1, MD
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
2122
;
23135
Related biomarkers:
Expression
Mutation
Others
‹
Chr inv(3)t(3;3) + MECOM overexpression (2)
KDM6B overexpression + TET2 deletion (1)
Chr inv(3)t(3;3) + MECOM overexpression (2)
KDM6B overexpression + TET2 deletion (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
MECOM mutation + KDM6B mutation
Myelodysplastic Syndrome
MECOM mutation + KDM6B mutation
Myelodysplastic Syndrome
lenalidomide
Sensitive: C3 – Early Trials
lenalidomide
Sensitive
:
C3
lenalidomide
Sensitive: C3 – Early Trials
lenalidomide
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.